Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.


TSXV:DHB - Post by User

Bullboard Posts
Post by Toptenconceptson Mar 04, 2019 4:13pm
184 Views
Post# 29440327

HVT Q3 revenue thread

HVT Q3 revenue threadPredict 

current revenue for q2. 3.7 + dva 1.5  = 5.2 

in Q3 

say 500 kgs of ganja  say 4 million 

dW. Say 2 million 

pills finally going say 500k 

dva revenue no increase say 1.5

8 million .. 

if if they can sell more ganja DW and pills might be 9 or 10 for q3 


q4 if if if they can get the ganja sells up 1250 kgs and boost others could see 15 million plus or 60 million annually rate .. eps .38 .. hmm x15 ... 5 bucks a share .. hold fast till Xmas 
Bullboard Posts